|
|
Received: 20 February 2017
Revised: 31 March 2017
Published: 10 October 2017
|
|
|
|
|
[1] 俞永新. 狂犬病和狂犬病疫苗[M] . 2版. 北京:中国医药科技出版社,2009. [2] 曹明华,胡岱霖,朱理业,等. 416例狂犬病发病影响因素分析[J] . 安徽预防医学杂志,2013,19(1):1-3,12. [3] 王玮,柴程良,孙继民,等. 浙江省 2008—2010年狂犬病流行特征分析[J] . 中国媒介生物学及控制杂志 ,2012,23(4):320-323. [4] WHO. WHO expert consultation on rabies[R] . Geneva:WHO,2013:982. [5] 周航,李昱,陈瑞丰,等. 狂犬病预防控制技术指南(2016版)[J] . 中华流行病学杂志,2016,37(2):139-163. [6] HUANG G,LIU H,TANG Q,et al. Making rabies prophylaxis more economical:immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers[J] . Human Vaccines & Immunotherapeutics,2014,10 (1):114-119. [7] HU Q,LIU M Q,ZHU Z G,et al. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China[J] . Human Vaccines & Immunotherapeutics,2014,10(6):1645-1649. [8] 奥海航,郝永发,齐喜娟,等. 宁夏 2011—2014 年狂犬病病例流行病学及临床特征分析[J] . 宁夏医科大学学报,2015,37(4):442-445. [9] 梅功超,姜威. 某州2006—2013年狂犬病的流行病学分析[J] . 中国医药指南,2015,13(13):9-11. [10] 叶国强. 2000—2012年湛江市狂犬病流行病学分析[J] . 预防医学情报杂志,2015,31(4):294-296. |
[1] |
. [J]. Preventive Medicine, 2019, 31(5): 482-483,487. |
|
|
|
|